Synonyms:
Status: Phase 3
Entry Type: Protein
Molecule Category: UKNOWN
UNII: X8Y5U6NC7E

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Angiopoietin-1 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Fallopian Tube Neoplasms 3 D005185 ClinicalTrials
Ovarian Neoplasms 3 D010051 ClinicalTrials
Peritoneal Neoplasms 3 D010534 ClinicalTrials
Prostatic Neoplasms 2 D011471 ClinicalTrials
Hemangiosarcoma 2 D006394 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Urinary Bladder Neoplasms 2 D001749 ClinicalTrials
Gliosarcoma 2 D018316 ClinicalTrials
Carcinoma, Hepatocellular 2 D006528 ClinicalTrials
Oligodendroglioma 2 D009837 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 1 D002289 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Central Nervous System Neoplasms 1 D016543 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2108568
FDA SRS X8Y5U6NC7E